Furthermore, KLK4 increases angiogenic activity in PCa, while it activates MMP-1 and thrombospondin-1, which facilitates and promotes lethal PCa bone metastasis [145,153]. The gene discussed is KLK4; the disease is posterior cortical atrophy.